Rationale and Design of the COPERNIC Trial: A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients.

Auteurs

Assaf I, Bregni G, Anthoine G, Aparicio T, Artru P, Abdelghani MB, Buyse M, Chibaudel B, Coart E, Diaz M, Evrard C, Geboes K, Ghiringhelli F, Puleo F, Raimbourg J, Vandamme T, Van den Eynde M, Hendlisz A, Sclafani F

  • Date de publication

    September 2024
  • Type

    Article
  • Review

    Clin Colorectal Cancer
  • Researcher's name

    HENDLISZ ALAIN
  • Hôpital

    Institut Jules Bordet
  • Service

    Médecine Oncologique, Oncologie digestive
  • PMID

    39341700
  • DOI

    10.1016/j.clcc.2024.08.004